Jacks Tyler 4

What Happened
Jacks Tyler, a director of Thermo Fisher Scientific, was granted 499 shares on May 20, 2026. The transaction is reported as an award/grant (transaction code A) with a reported acquisition price of $0.00 per share (total reported value $0). This is an issuance/award of shares rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-20 (award/grant, code A)
• Shares acquired: 499
• Reported price/value: $0.00 per share; total reported value $0
• Filing date: 2026-05-22 (period of report 2026-05-20) — appears filed within the standard 2-business-day window
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• Footnotes/exhibits: Exhibit 24 (Power of Attorney) included; no 10b5-1 plan, tax-withholding, or additional footnotes shown in the excerpt

Context
Equity awards to directors are commonly part of compensation packages and often vest over time; they represent grants from the company rather than purchases on the open market, so they don’t directly signal the director buying or selling stock. For retail investors, such awards can modestly dilute existing shareholders over time but should be interpreted as compensation-related, not necessarily an endorsement or rejection of the company’s near-term prospects.